Lupin Healthcare (UK) Limited has informed the MHRA that affected batches of Simvastatin tablets have been packaged with a version of patient information leaflet that does not include the most up to date safety information. Further details of the affected batches and advice for healthcare professionals can be found on the MHRA website.
Want the latest pharmacy news and updates straight to your inbox?
Sign up to our regular newsletter for the latest guidance, news, events and CPD opportunities.
Sign Up